Physician

Rami K Taha, M.D.

According to 2025 Medicare claims, Rami Taha, M.D. (NPI: 1881872588) practices internal medicine in the Lake County, IL market, with the plurality of this provider's patient population coming from Lake, IL. This provider's primary affiliated billing organization is INFECTIOUS DISEASE CONSULTANTS OF NORTHERN ILLINOIS S.C. (NPI: 1356680300; TIN: 461982951) and primary practice location at 60048-3199.

Taha's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 985 traditional Medicare patients, billed 4,893 HCPCS/CPT codes, and received $542,722 in Medicare payments. The top billing code was 99306 (Initial nursing facility care with high level of medical decision making, per day, if using time, 50 minutes or more). Part D data shows 613 prescription claims across 210 beneficiaries totaling $195,999 in drug costs, led by Genvoya (Elviteg/Cob/Emtri/Tenof Alafen). 2023 DME data shows 45 claims. Open Payments data shows 5 records totaling $90. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $361,517 to $542,722. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $170,128 and ending at $195,999. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $16,833 and ending at $10,977.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	920	4,759	$361,517
2016	768	4,083	$320,751
2017	748	4,225	$336,522
2018	725	4,956	$347,731
2019	785	5,905	$407,537
2020	943	5,248	$440,966
2021	950	5,523	$460,054
2022	932	4,766	$436,586
2023	865	4,923	$502,589
2024	985	4,893	$542,722

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	205	616	$170,128
2016	181	542	$197,484
2017	226	714	$339,970
2018	230	698	$278,986
2019	228	793	$388,214
2020	204	697	$263,463
2021	192	647	$447,622
2022	181	603	$290,565
2023	219	622	$178,273
2024	210	613	$195,999

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	50	$1,658
2016	N/R	N/R	N/R
2017	N/R	24	$8,087
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	24	63	$8,459
2021	22	57	$2,518
2022	51	72	$10,459
2023	N/R	45	$7,228
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99306	Initial nursing facility care with high level of medical decision making, per day, if using time, 50 minutes or more	160	176	$159
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	546	661	$145
99310	Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes	116	200	$135
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	657	2,958	$103
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	208	419	$100

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Genvoya	Elviteg/Cob/Emtri/Tenof Alafen	27	810	$103,655
Daptomycin	Daptomycin	39	248	$27,385
Ertapenem	Ertapenem Sodium	27	177	$8,155
Meropenem	Meropenem	11	71	$4,224
Doxycycline Hyclate	Doxycycline Hyclate	54	1,822	$2,013

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$90	AIMMUNE THERAPEUTICS, INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Rami K. Taha, M.D.?

Tedicare shows public-source Medicare data for Rami K. Taha, M.D. (NPI 1881872588), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rami K. Taha, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Rami K. Taha, M.D.?

Rami K. Taha, M.D. is linked to INFECTIOUS DISEASE CONSULTANTS OF NORTHERN ILLINOIS S.C. (billing NPI 1356680300) in the available physician profile data.

Does Rami K. Taha, M.D. have Open Payments data?

Rami K. Taha, M.D. has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.